Oric Pharmaceuticals (ORIC) News Today $10.82 +0.04 (+0.32%) As of 09:43 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ORIC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Fred Alger Management LLC Sells 40,554 Shares of Oric Pharmaceuticals, Inc. $ORICSeptember 12 at 5:20 AM | marketbeat.comTrexquant Investment LP Invests $425,000 in Oric Pharmaceuticals, Inc. $ORICSeptember 10, 2025 | marketbeat.com203,006 Shares in Oric Pharmaceuticals, Inc. $ORIC Bought by Parkman Healthcare Partners LLCSeptember 8, 2025 | marketbeat.comORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)September 5, 2025 | globenewswire.comOric Pharmaceuticals, Inc. $ORIC Shares Bought by Rafferty Asset Management LLCSeptember 5, 2025 | marketbeat.comOric Pharmaceuticals assumed with a Buy at GuggenheimSeptember 4, 2025 | msn.comAlkeon Capital Management LLC Buys 100,000 Shares of Oric Pharmaceuticals, Inc. $ORICSeptember 4, 2025 | marketbeat.comMPM Bioimpact LLC Takes $7.81 Million Position in Oric Pharmaceuticals, Inc. $ORICSeptember 4, 2025 | marketbeat.comFrazier Life Sciences Management L.P. Has $7.87 Million Stock Position in Oric Pharmaceuticals, Inc. $ORICSeptember 4, 2025 | marketbeat.comORIC Pharmaceuticals, Inc. (ORIC) Pharmaceuticals, Inc. Presents at Citi's Biopharma Back to School Conference - SlideshowSeptember 3, 2025 | seekingalpha.comORIC Pharmaceuticals, Inc. (ORIC) Pharmaceuticals, Inc. Presents At Citi's Biopharma Back To School Conference TranscriptSeptember 3, 2025 | seekingalpha.comStocks To Watch: Oric Pharmaceuticals Sees RS Rating Jump To 82September 3, 2025 | msn.comNuveen LLC Makes New Investment in Oric Pharmaceuticals, Inc. $ORICSeptember 3, 2025 | marketbeat.comDAFNA Capital Management LLC Purchases New Holdings in Oric Pharmaceuticals, Inc. $ORICSeptember 1, 2025 | marketbeat.comORIC® Pharmaceuticals to Participate in Upcoming Investor ConferencesAugust 27, 2025 | globenewswire.comOric Pharmaceuticals, Inc. (NASDAQ:ORIC) Given Average Rating of "Moderate Buy" by BrokeragesAugust 27, 2025 | marketbeat.comThis ORIC Pharmaceuticals Insider Increased Their Holding In The Last YearAugust 24, 2025 | finance.yahoo.comOric Pharmaceuticals, Inc. (NASDAQ:ORIC) Short Interest Down 45.0% in JulyAugust 20, 2025 | marketbeat.comORIC Pharmaceuticals: ORIC Pharmaceuticals Expands Leadership Team with the Appointment of Kevin Brodbeck as Chief Technical OfficerAugust 19, 2025 | finanznachrichten.deORIC Pharmaceuticals Reports Q2 2025 Financial ResultsAugust 19, 2025 | msn.comOric Pharmaceuticals appoints Kevin Brodbeck CTOAugust 19, 2025 | msn.comEquities Analysts Offer Predictions for ORIC Q3 EarningsAugust 19, 2025 | marketbeat.comORIC® Pharmaceuticals Expands Leadership Team with the Appointment of Kevin Brodbeck as Chief Technical OfficerAugust 18, 2025 | globenewswire.comWedbush Predicts Weaker Earnings for Oric PharmaceuticalsAugust 17, 2025 | marketbeat.comOric Pharmaceuticals (NASDAQ:ORIC) Upgraded to Hold at Zacks ResearchAugust 17, 2025 | marketbeat.comJPMorgan Chase & Co. Has Lowered Expectations for Oric Pharmaceuticals (NASDAQ:ORIC) Stock PriceAugust 16, 2025 | marketbeat.comOric Pharmaceuticals (NASDAQ:ORIC) Given New $19.00 Price Target at HC WainwrightAugust 16, 2025 | marketbeat.comOric Pharmaceuticals' (ORIC) Buy Rating Reiterated at GuggenheimAugust 15, 2025 | marketbeat.comOric Pharmaceuticals (NASDAQ:ORIC) Posts Earnings Results, Misses Expectations By $0.01 EPSAugust 14, 2025 | marketbeat.comOric Pharmaceuticals Focuses on Lead Clinical ProgramsAugust 12, 2025 | msn.comOric Pharmaceuticals reports Q2 EPS (47c), consensus (44c)August 12, 2025 | msn.comOric Pharmaceuticals Logs Wider 2Q Loss, Plans to Cut 20% of WorkforceAugust 12, 2025 | marketwatch.comORIC® Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational UpdatesAugust 12, 2025 | globenewswire.comVivo Capital LLC Purchases 802,632 Shares of Oric Pharmaceuticals, Inc. (NASDAQ:ORIC)August 9, 2025 | marketbeat.comORIC Pharmaceuticals: What It Takes To Be Best In ClassAugust 7, 2025 | seekingalpha.comOric Pharmaceuticals (ORIC) to Release Earnings on MondayAugust 5, 2025 | marketbeat.comORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)August 1, 2025 | globenewswire.comVictory Capital Management Inc. Purchases 52,760 Shares of Oric Pharmaceuticals, Inc. (NASDAQ:ORIC)August 1, 2025 | marketbeat.comOric Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Consensus Rating of "Buy" from BrokeragesJuly 31, 2025 | marketbeat.comOric Pharmaceuticals (NASDAQ:ORIC) Shares Down 8.2% - Here's What HappenedJuly 30, 2025 | marketbeat.comNew York State Common Retirement Fund Has $215,000 Stock Position in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC)July 27, 2025 | marketbeat.comOric Pharmaceuticals, Inc. (ORIC) Now Trades Above Golden Cross: Time to Buy?July 15, 2025 | finance.yahoo.comOric Pharmaceuticals, Inc. (ORIC) is a Great Momentum Stock ... - NasdaqJuly 13, 2025 | nasdaq.comOric Pharmaceuticals (NASDAQ:ORIC) Shares Down 4.9% - Here's What HappenedJuly 11, 2025 | marketbeat.comLadenburg Thalmann Initiates Coverage of ORIC Pharmaceuticals (ORIC) with Buy RecommendationJuly 9, 2025 | msn.comOric Pharmaceuticals (NASDAQ:ORIC) Now Covered by LADENBURG THALM/SH SHJuly 8, 2025 | marketbeat.comOric Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Consensus Recommendation of "Buy" from AnalystsJuly 6, 2025 | marketbeat.comORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635 (c) (4) - MorningstarJuly 5, 2025 | morningstar.comMORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)July 3, 2025 | globenewswire.comMetastatic Prostate Cancer Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsightJuly 3, 2025 | theglobeandmail.com Get Oric Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ORIC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ORIC Media Mentions By Week ORIC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ORIC News Sentiment▼1.770.94▲Average Medical News Sentiment ORIC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ORIC Articles This Week▼45▲ORIC Articles Average Week Get the Latest News and Ratings for ORIC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Oric Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Arcellx News Today ADMA Biologics News Today Arrowhead Pharmaceuticals News Today Jyong Biotech News Today Mirum Pharmaceuticals News Today MoonLake Immunotherapeutics News Today Metsera News Today Protagonist Therapeutics News Today Ascentage Pharma Group International News Today Lantheus News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ORIC) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oric Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oric Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
